Science Explorer Back to mapMap
Discussion
Researcher · Charité - Universitätsmedizin Berlin · Germany

Andreas Diefenbach

Andreas Diefenbach publishes mostly in Immunology, Surgery and Infectious Diseases, on topics such as Immune Cell Function and Interaction, IL-33, ST2, and ILC Pathways and Eosinophilic Esophagitis.

ORCID 0000-0002-9176-9530 OpenAlex
World rank
#32,415
of 7,710,434 ranked researchers
Rank in Germany
#1,902
of 364,343
Works
183
Citations
36k
Citations per work
198.7
h-index
64
i10-index 123Top 2.1% in Immunology
Andreas Diefenbach

What does Andreas Diefenbach research?

Andreas Diefenbach's work is mostly in Immunology and Microbiology (53%), Medicine (21%), Biochemistry, Genetics and Molecular Biology (5%).

Life Sciences: 107 works · 58.2% of their workImmunology and Microbiology: 98 works · 53.4% of their workImmunology: 98 works · 53.4% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 4.8% of their workMolecular Biology: 9 works · 4.8% of their workEverything else: 39 works · 21.2% of their workHealth Sciences: 38 works · 20.6% of their workMedicine: 38 works · 20.6% of their workSurgery: 16 works · 9.0% of their workInfectious Diseases: 11 works · 6.0% of their workPublic Health, Environmental and Occupational Health: 6 works · 3.2% of their workEpidemiology: 4 works · 2.4% of their workTHEIR WORKAndreasDiefenbach183works
Life Sciences58%Health Sciences21%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology9853.4%
    2. Biochemistry, Genetics and Molecular Biology94.8%
  2. Everything else3921.2%
    1. Medicine3820.6%
  1. 1Immunology53% of their works
  2. 2Surgery9% of their works
  3. 3Infectious Diseases6% of their works
  4. 4Molecular Biology5% of their works
  5. 5Public Health, Environmental and Occupational Health3% of their works
  6. 6Epidemiology2% of their works

Research topics

Which keywords describe Andreas Diefenbach's research?

The keywords of their largest research topics: Natural Killer Cells, NK Cell Recognition, Inflammatory Diseases, IL-33, Innate Lymphoid Cells, Diagnosis, Treatment and Eosinophilic Esophagitis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. NK Cell Recognition1041 topic
  2. Natural Killer Cells1041 topic
  3. Inflammatory Diseases932 topics
  4. IL-33851 topic
  5. Innate Lymphoid Cells851 topic
  6. Diagnosis502 topics
  7. Treatment502 topics
  8. Eosinophilic Esophagitis381 topic
  9. Management381 topic
  10. Foxp3341 topic
  11. TGF-ß341 topic
  12. Immunity323 topics
  13. Leishmaniasis121 topic
  14. Parasite121 topic
  15. Cancer Immunotherapy111 topic
  16. Dendritic Cells111 topic
  17. Coronavirus91 topic
  18. SARS-CoV-291 topic
  19. Gut Microbiota81 topic
  20. Microbial Communities81 topic

Where does Andreas Diefenbach work?

Andreas Diefenbach's main affiliation in the publication record is Charité - Universitätsmedizin Berlin, Germany.

How many publications and citations does Andreas Diefenbach have?

OpenAlex counts 183 works and 36,356 citations for Andreas Diefenbach, an h-index of 64, ranking #32,415 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Andreas Diefenbach. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.